{
    "2019-11-05": [
        [
            {
                "time": "2018-10-24",
                "original_text": "Vanguard Health Care Fund Sells Out of Allergan",
                "features": {
                    "keywords": [
                        "Vanguard",
                        "Health Care Fund",
                        "Sells",
                        "Allergan"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-11-05",
                "original_text": "Allergan (AGN) Meets Q3 Earnings Estimates, Ups '19 Sales View",
                "features": {
                    "keywords": [
                        "Allergan",
                        "Q3",
                        "Earnings",
                        "Estimates",
                        "Sales",
                        "View"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-11-05",
                "original_text": "Allergan's Q3 Sales Get A Facelift From Botox; AbbVie Deal On Track",
                "features": {
                    "keywords": [
                        "Allergan",
                        "Q3",
                        "Sales",
                        "Botox",
                        "AbbVie",
                        "Deal"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-11-06",
                "original_text": "The Zacks Analyst Blog Highlights: Group 1 Automotive, AbbVie, Brinker International, Hewlett Packard and Bristol-Myers Squibb",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst",
                        "Blog",
                        "Group 1 Automotive",
                        "AbbVie",
                        "Brinker International",
                        "Hewlett Packard",
                        "Bristol-Myers Squibb"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "technology",
                        "consumer goods"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-11-05",
                "original_text": "[video]Allergan Tops Q3 Earnings, Bumps 2019 Sales Guidance Amid AbbVie Takeover",
                "features": {
                    "keywords": [
                        "Allergan",
                        "Q3",
                        "Earnings",
                        "Sales",
                        "Guidance",
                        "AbbVie",
                        "Takeover"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-11-05",
                "original_text": "Allergan Tops Q3 Earnings, Bumps 2019 Sales Guidance Amid AbbVie Takeover",
                "features": {
                    "keywords": [
                        "Allergan",
                        "Q3",
                        "Earnings",
                        "Sales",
                        "Guidance",
                        "AbbVie",
                        "Takeover"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}